Linezolid IV Injection [100 mL]

Standard IV antibiotic, effective against resistant bacteria like MRSA

Volume: 100 mL
Composition: 0.6 g linezolid (antibiotic drug) in 300 mL of saline or dextrose solution
Use Case: To treat serious infections (e.g., MRSA, pneumonia, skin infections) in hospital settings
Packaging: BFS/FFS/Eurohead
Usual Expiry: 2 years
Storage Temprature: 15-25°C

Description

Linezolid Injection is a sterile, intravenous solution containing linezolid, an oxazolidinone antibiotic. It is indicated for the treatment of serious infections caused by susceptible gram-positive bacteria, including vancomycin-resistant Enterococcus faecium (VRE) infections, methicillin-resistant Staphylococcus aureus (MRSA) infections, and nosocomial pneumonia. This medication is administered intravenously for patients with severe infections or when oral administration is not feasible.

This product is indicated for specific medical conditions and must be administered intravenously by trained medical professionals. Strict monitoring of patient condition and electrolyte balance is essential.

Additional information

Linezolid IV Injection [100 mL]

Related products

ELECTROLYTE – E [500 mL]

Ringer (R) INJ. [500 mL]

Dextrose & Normal Saline (DNS) – 0.9% & 5% INJ. [500 mL]

Dextrose (D20) – 20 % INJ. [500 mL]